Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Bioadaptives (BDPT) Receivables - Other (2019 - 2025)

Bioadaptives' Receivables - Other history spans 4 years, with the latest figure at $2800.0 for Q3 2025.

  • Quarterly results put Receivables - Other at $2800.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $2800.0 (changed N/A YoY), and the annual figure for FY2024 was $2800.0, changed.
  • Receivables - Other for Q3 2025 was $2800.0 at Bioadaptives, roughly flat from $2800.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $2800.0 in Q4 2024 to a low of $1623.0 in Q1 2021.
  • The 3-year median for Receivables - Other is $2800.0 (2024), against an average of $2295.6.